CLBT
Cellebrite DI
NASDAQ: CLBT · TECHNOLOGY · SOFTWARE - INFRASTRUCTURE
$12.84
+0.00% today
Updated 2026-06-12
Market cap
$3.20B
P/E ratio
45.86
P/S ratio
6.45x
EPS (TTM)
$0.28
Dividend yield
—
52W range
$11 – $20
Volume
2.2M
WallStSmart proprietary scores
40
out of 100
Grade: D
Sell
Investment rating
6.7
Growth
B6.5
Quality
B6.0
Profitability
B3.7
Valuation
D2/9
Piotroski F-Score
Weak
1.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$21.75
+69.39%
12-Month target
$9.30
-27.57%
Intrinsic (DCF)
$7.83
Margin of safety
-63.98%
2 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $16.84M — positive
+ Revenue growth 19.30% QoQ
+ Debt/equity 0.04x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 1.60 — distress zone
- 63.98% above intrinsic value
- P/E 45.86x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $270.65M | $325.11M | $401.20M | $475.68M | $496.43M | $0.6B |
| Net income | $120.81M | $-81.10M | $-283.01M | $78.33M | $10.94M | — |
| EPS | — | — | — | — | $0.28 | $0.62 |
| Free cash flow | $11.49M | $94.14M | $121.56M | $155.73M | $16.84M | — |
| Profit margin | 44.63% | -24.95% | -70.54% | 16.47% | 14.50% | — |
Peer comparison
Smart narrative
Cellebrite DI trades at $12.84. representing a P/E of 45.86x trailing earnings. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 1.60, it sits in the distress. TTM revenue stands at $496.43M. with profit margins at 14.50%. Our DCF model estimates intrinsic value at $7.83.
Frequently asked questions
What is Cellebrite DI's stock price?
Cellebrite DI (CLBT) trades at $12.84, on a P/E of 45.9x and a P/S of 6.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Cellebrite DI overvalued?
Cellebrite DI carries a Smart Value Score of 40/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $7.83 against the $12.84 price, so on cash flow terms the market is paying a premium for Cellebrite DI's growth. The Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Cellebrite DI (CLBT)?
The 12-month analyst consensus target is $21.75, about 69.4% above the current $12.84. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of CLBT by 2030?
Our research-backed model puts the 2030 base case at $16.82, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of Cellebrite DI (CLBT)?
Our DCF model estimates intrinsic value at $7.83, a -64.0% margin of safety versus today's $12.84. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Cellebrite DI's revenue?
Cellebrite DI's trailing twelve-month revenue is $496.43M, and our model projects it reaching about $1.19B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Cellebrite DI's Altman Z-Score is 1.60, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorTECHNOLOGY
IndustrySOFTWARE - INFRASTRUCTURE
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.45x
ROE14.08%
Beta1.17
50D MA$13.23
200D MA$15.80
Shares out0.25B
Float0.12B
Short ratio—
Avg volume2.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—